cbdMD (YCBD) Preferred Dividend Payments (2019 - 2026)
cbdMD (YCBD) posted Preferred Dividend Payments of $41471.0 for Q4 2025, down 87.56% sequentially from $333500.0 in Q2 2025, and down 95.85% YoY from $1.0 million in Q4 2024.
cbdMD (YCBD) Preferred Dividend Payments (2019 - 2026) Analysis & Trends
cbdMD has reported Preferred Dividend Payments for 7 years, with the latest figure at $41471.0 in Q4 2025.
- Quarterly Preferred Dividend Payments fell 95.85% year-over-year to $41471.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 65.65% YoY) and the FY2025 annual result came in at $2.3 million, down 41.7% from the prior year.
- Preferred Dividend Payments eased to $41471.0 in Q4 2025 per YCBD's latest filing, from $333500.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $1.3 million in Q3 2021 and troughed at $41471.0 in Q4 2025.
- A 5-year average of $886238.9 and a median of $1.0 million in 2022 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2021 and 2025: Preferred Dividend Payments jumped 1233.33% in 2021, then slumped 95.85% in 2025.
- Over 5 years, Preferred Dividend Payments stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then dropped by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then plunged by 95.85% to $41471.0 in 2025.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $41471.0, $333500.0, and $1.0 million for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 71,031.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71,031.00 |
| Dec 31, 2025 | 41,471.00 |
| Jun 30, 2025 | 333,500.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | 560,281.00 |
| Mar 31, 2021 | 560,280.00 |